For its ability to reduce the incidence of disability, a procedure called endovascular therapy (ET) could be the best option for many stroke sufferers, says a study co-authored by an Indian-origin doctor.
"Endovascular treatment using stent retrievers will become the standard of care for patients with acute ischemic stroke," said Mayank Goyal from University of Calgary in Canada.
The clinical trial randomised 196 patients to receive either t-PA, a clot busting drug, or tPA plus ET.
ET is performed by inserting a thin tube into the artery in the groin, through the body and into the brain vessels to the clot. This is done under image-guided care using an X-ray.
The clot is then removed by a retrievable stent and pulled out, restoring blood flow to the brain. Overall, positive outcomes for patients increased from 35 percent to 60 percent, the researchers noted.
The study was published in the New England Journal of Medicine.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
